01:33 , Sep 13, 2014 |  BC Extra  |  Financial News

Affimed raises $56M in IPO

Affimed Therapeutics B.V. (NASDAQ:AFMD) was down $1.30 to $5.70 on its first day of trading Friday after raising $56 million through the sale of 8 million shares at $7 in an IPO. The IPO price...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Company News

Formycon, Santo Holding GmbH deal

In December, Formycon (formerly Nanohale AG) granted investment holding company Santo exclusive, worldwide rights to develop and commercialize an undisclosed biosimilar product. This is the biosimilar company's first licensing deal. Formycon will conduct all...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

Nanohale, Scil Technology deal

Nanohale acquired Scil Technology for an undisclosed sum. Scil will become part of Nanohale's newly-formed Formycon GmbH subsidiary. Nanohale said that Scil Technology's protein drug development, formulation and analytics programs complement Nanohale's existing protein formulation....